91Â鶹ÌìÃÀÖ±²¥

Skip to main content
Chakravarthy B. Reddy
( out of 42 reviews )

Chakravarthy B. Reddy, MD

Languages spoken: English

Clinical Locations

University of Utah Hospital

Salt Lake City
801-581-7806
  • Chakravarthy Reddy, MD, is an Huntsman Cancer Institute investigator and assistant professor in the Department of Medicine at the University of Utah School of Medicine. He specializes in lung cancer, airway disorders, and malignant pleural effusion. He is interested in advancing non-surgical ways to diagnose and treat cancers that occur in the chest. He performs flexible and rigid bronchoscopy, pleuroscopy, endobronchial ultrasonography, and airway stent placements.

    Reddy attended Mysore Medical College in Mysore, Karnataka, India. He completed an internship and residency at St. Barnabas Hospital in the Bronx, New York, where he also served as attending physician. He completed a fellowship in pulmonary and critical care medicine at the University of Utah School of Medicine and received additional training in interventional pulmonology medicine at Harvard Medical School.

    Reddy is a certified member of the American Board of Internal Medicine, the American Association of Bronchology, the American College of Chest Physicians, and the American Thoracic Society.

    Reddy volunteers and does community service locally and internationally. He has performed health care screenings in Africa and Ecuador.

    Board Certification

    American Association for Bronchology and Interventional Pulmonology
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Patient Rating

    4.9 /5
    ( out of 42 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 01, 2024
    HUNTSMAN CANCER CENTER

    Very caring, he listens to all my concerns and answers my questions in a manner that I can understand very knowledgeable I'm very pleased

    July 19, 2024
    HUNTSMAN CANCER CENTER

    Dr. Reddy is kind and bright. He explains what I need and why and in spite of seeing so many patients he knows who I am and why I am there.

    July 13, 2024
    HUNTSMAN CANCER CENTER

    Love this Dr he is very good and has a kind patient bedside manner highly recommend!

    July 11, 2024
    HUNTSMAN CANCER CENTER

    Doctor, Reddy was wonderful with our concern's

    July 07, 2024
    HUNTSMAN CANCER CENTER

    Great knowledge, very professional, took time to answer my questions,

    June 29, 2024
    HUNTSMAN CANCER CENTER

    Muy profesional

    June 28, 2024
    HUNTSMAN CANCER CENTER

    Dr Reddy was great.

    June 14, 2024
    HUNTSMAN CANCER CENTER

    I highly recommend Dr. Reddy.

    June 07, 2024
    HUNTSMAN CANCER CENTER

    Fine caring and understanding Doctor

  • Chakravarthy Reddy, MD, is an Huntsman Cancer Institute investigator and assistant professor in the Department of Medicine at the University of Utah School of Medicine. He specializes in lung cancer, airway disorders, and malignant pleural effusion. He is interested in advancing non-surgical ways to diagnose and treat cancers that occur in the chest. He performs flexible and rigid bronchoscopy, pleuroscopy, endobronchial ultrasonography, and airway stent placements.

    Reddy attended Mysore Medical College in Mysore, Karnataka, India. He completed an internship and residency at St. Barnabas Hospital in the Bronx, New York, where he also served as attending physician. He completed a fellowship in pulmonary and critical care medicine at the University of Utah School of Medicine and received additional training in interventional pulmonology medicine at Harvard Medical School.

    Reddy is a certified member of the American Board of Internal Medicine, the American Association of Bronchology, the American College of Chest Physicians, and the American Thoracic Society.

    Reddy volunteers and does community service locally and internationally. He has performed health care screenings in Africa and Ecuador.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Public Health
    Board Certification
    American Association for Bronchology and Interventional Pulmonology
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Education history

    Biomedical Engineering - University of Utah MS
    Fellowship Interventional Pulmonology - Harvard Medical School, Beth Israel Deaconess Medical Center Fellow
    Fellowship Pulmonary/Critical Care - University of Utah School of Medicine Fellow
    Internship Internal Medicine - St. Barnabas Hospital Intern
    Residency Internal Medicine - St. Barnabas Hospital Resident
    Clerkship Internal Medicine - Weill Medical College of Cornell University Clinical Clerkship
    Internship General Medicine/Surgery - Krishna Rajendra Hospital Intern
    Professional Medical Mysore Medical College M.B.B.S.
    Undergraduate S. S. Pre-University College

    Selected Publications

    Journal Article

    1. Wang H, Yuan Z, Pavel MA, Jablonski SM, Jablonski J, Hobson R, Valente S, Reddy CB, Hansen SB (2023). The role of high cholesterol in SARS-CoV-2 infectivity. J Biol Chem, 104763. ()
    2. Raza HA, Raja MHR, Chambers JH, Reddy CB, Shafiq M (2023). Bronchoscopic Management of Hemoptysis Caused by Airway Erosion From Vascular Coils. J Bronchology Interv Pulmonol. ()
    3. Reddy C, Sethi J, Balwan A, Iravani A, Ansari S, Kelly K (2023). Aerosol Generation During Bronchoscopy. J Bronchology Interv Pulmonol, 30(1), 7-15. ()
    4. Akulian J, Bedawi EO, Abbas H, Argento C, Arnold DT, Balwan A, Batra H, Uribe Becerra JP, Belanger A, Berger K, Burks AC, Chang J, Chrissian AA, DiBardino DM, Fuentes XF, Gesthalter YB, Gilbert CR, Glisinski K, Godfrey M, Gorden JA, Grosu H, Gupta M, Kheir F, Ma KC, Majid A, Maldonado F, Maskell NA, Mehta H, Mercer J, Mullon J, Nelson D, Nguyen E, Pickering EM, Puchalski J, Reddy C, Revelo AE, Roller L, Sachdeva A, Sanchez T, Sathyanarayan P, Semaan R, Senitko M, Shojaee S, Story R, Thiboutot J, Wahidi M, Wilshire CL, Yu D, Zouk A, Rahman NM, Yarmus L, Interventional Pulmonary Outcomes Group (2022). Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study. Chest, 162(6), 1384-1392. ()
    5. Yuan Z, Pavel MA, Wang H, Kwachukwu JC, Mediouni S, Jablonski JA, Nettles KW, Reddy CB, Valente ST, Hansen SB (2022). Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture. Commun Biol, 5(1), 958. ()
    6. Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes M (2022). NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw, 20(7), 754-764. ()
    7. Lee HJ, Argento AC, Batra H, Benzaquen S, Bramley K, Chambers D, Desai N, Dincer HE, Ferguson JS, Kalanjeri S, Lamb C, Meena N, Reddy C, Revelo A, Sachdeva A, Seides B, Shah H, Shojaee S, Sonetti D, Thiboutot J, Toth J, Van Nostrand K, Akulian JA (2022). A Multicenter Study Assessing Interventional Pulmonary Fellow Competency in Electromagnetic Navigation Bronchoscopy. ATS Sch, 3(2), 220-228. ()
    8. Shrager JB, Bhatnagar R, Kearney CT, Retzlaff NP, Cohen E, Stanton AE, Keyes C, Wahidi MM, Gillespie C, Rahman N, Kerry AL, Feller-Kopman D, Nader D, Akulian J, Chen A, Berry M, Majid A, Reddy C, Tremblay A, Maskell NA (2022). Silver Nitrate-Coated Versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial. Ann Am Thorac Soc. ()
    9. Sarkar V, Szegedi M, Paxton A, Nelson G, Rassiah-Szegedi P, Reddy CB, Tao R, Hitchcock YJ, Kokeny KE, Salter BJ (2020). Preliminary clinical experience with Calypso anchored beacons for tumor tracking in lung SBRT. Med Phys, 47(9), 4407-4415. ()
    10. Reddy C, Ernst A, Lamb C, Feller-Kopman D (2010). Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest, 139(6), 1419-1423. ()
    11. Reddy C (2009). Bronchoprovocation testing. Clin Rev Allergy Immunol, 37(3), 167-72. ()

    Review

    1. Reddy C, Chilla D, Boltax J (2011). Lung cancer screening: a review of available data and current guidelines. [Review]. Hosp Pract (1995), 39(4), 107-12. ()

    Letter

    1. Iravani A, Reddy C (2022). Use of Self-expanding Metallic Y Stent in the United States: First Report. [Letter to the editor]. J Bronchology Interv Pulmonol, 29(2), e23-e25. ()

    Other

    1. Yuan Z, Pavel MA, Wang H, Kwachukwu JC, Mediouni S, Jablonski JA, Nettles KW, Reddy CB, Valente ST, Hansen SB (2022). Author Correction: Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture. Commun Biol (5(1), p. 1164). England. ()
    2. Wang H, Yuan Z, Pavel MA, Jablonski SM, Jablonski J, Hobson R, Valente S, Reddy CB, Hansen SB (2021). The role of high cholesterol in age-related COVID19 lethality. United States. ()
    3. Wilshire CL, Chang SC, Gilbert CR, Akulian JA, AlSarraj MK, Asciak R, Bevill BT, Davidson KR, Delgado A, Grosu HB, Herth FJF, Lee HJ, Lewis JE, Maldonado F, Ost DE, Pastis NJ, Rahman NM, Reddy CB, Roller LJ, Sanchez TM, Shojaee S, Steer H, Thiboutot J, Wahidi MM, Wright AN, Yarmus LB, Gorden JA (2020). Temporal Trends in Tunneled Pleural Catheter Utilization in Patients With Malignancy: A Multicenter Review. Chest (159(6), pp. 2483-2487). United States. ()
    4. Wilshire CL, Chang SC, Gilbert CR, Akulian JA, AlSarraj MK, Asciak R, Bevill BT, Davidson KR, Delgado A, Grosu HB, Herth FJF, Lee HJ, Lewis JE, Maldonado F, Ost DE, Pastis NJ, Rahman NM, Reddy CB, Roller LJ, Sanchez TM, Shojaee S, Steer H, Thiboutot J, Wahidi MM, Wright AN, Yarmus LB, Gorden JA (2020). Association between Tunneled Pleural Catheter Use and Infection in Patients Immunosuppressed from Antineoplastic Therapy. A Multicenter Study. Ann Am Thorac Soc (18(4), pp. 606-612). United States. ()
    5. Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, Lazarus DR, Casal R, Benzaquen SB, Holladay RC, Wellikoff A, Calero K, Rumbak MJ, Branca PR, Abu-Hijleh M, Mallea JM, Kalhan R, Sachdeva A, Kinsey CM, Lamb CR, Reed MF, Abouzgheib WB, Kaplan PV, Marrujo GX, Johnstone DW, Gasparri MG, Meade AA, Hergott CA, Reddy C, Mularski RA, Case AH, Makani SS, Shepherd RW, Chen B, Holt GE, Martel S (2019). Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial. Am J Respir Crit Care Med (200(11), pp. 1354-1362). United States. ()
    6. Grosu HB, Molina S, Casal R, Song J, Li L, Diaz-Mendoza J, Reddy C, Yarmus L, Schiavo D, Simoff M, Johnstun J, Raid AA, Feller-Kopman D, Lee H, Sahetya S, Foley F, Maldonado F, Tian X, Noor L, Miller R, Mudambi L, Saettele T, Vial-Rodriguez M, Eapen GA, Ost DE (2018). Risk factors for pleural effusion recurrence in patients with malignancy. Respirology (24(1), pp. 76-82). Australia. ()
    7. Wood DE, Kazerooni E, Baum SL, Dransfield MT, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Leung AN, Makani SS, Massion PP, Meyers BF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Sequist LV, Tong BC, Travis WD, Yang SC, Gregory KM, Hughes M, National comprehension cancer network (2015). Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (13(1), pp. 23-34; quiz 34). United States. ()

    Patent

    1. (2022). Positive pressure ventilation appliance modules and related systems and methods. U.S. Patent No. US20220370750A1. Washington, D.C.:U.S. Patent and Trademark Office.
  • Clinical Trials